KZR
Kezar Life Sciences Inc
0.175$
+6.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | +374.6% | +111.5% | -21.9% | +69.6% | +43.5% | +37.5% | -26.1% | -34.6% | -47.0% | |
| – | +399.0% | +109.8% | -26.1% | +78.5% | +46.2% | +35.0% | -27.6% | -33.6% | -44.9% | |
| – | +423.6% | -52.6% | -38.2% | +42.0% | +196.2% | -35.7% | -12.3% | +17.6% | +72.2% | |
| – | +423.6% | +110.5% | -27.2% | +79.6% | +48.4% | +32.7% | -27.2% | -34.3% | -45.6% | |
| – | +32.1% | -99.0% | +12,740.0% | +19.3% | -90.9% | – | – | -81.5% | +354.0% | |
| – | – | – | – | +59.1% | +27.1% | – | – | – | – | |
| – | +78.7% | +198.4% | +76.3% | -57.6% | -4.4% | +4.5% | – | – | – | |
| – | +177.0% | -92.6% | +94.9% | -5.3% | +93.8% | +41.0% | +13.4% | -17.5% | -76.3% | |
| – | +128.0% | +124.9% | +79.9% | +7.3% | +27.5% | +33.9% | +61.4% | +14.6% | -67.7% | |
| – | – | – | – | +15.8% | +15.1% | +113.9% | +17.4% | +190.3% | -73.4% | |
| – | +17.4% | -64.7% | +326.4% | +186.5% | -14.0% | +22.2% | +232.8% | -55.8% | -86.1% | |
| – | – | – | – | – | – | +2.2% | +2.4% | -49.2% | – | |
| – | – | – | -28.3% | +80.6% | +39.7% | +37.1% | -30.5% | -37.7% | -40.1% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +46.1% | +0.3% | +130.6% | +19.9% | +27.7% | +7.7% | +0.5% | -90.0% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.